New Creamino® Sales and Distribution partner in Canada
Creamino® has a new distributor in Canada - Protekta.
We are pleased to have Protekta as our Sales and Distribution partner for Creamino® in Canada. Their contacts in the industry and their dedication to representing technically sound feed additives are a perfect fit for AlzChem. We anticipate great success in working with Protekta to introduce the benefits of Creamino® to Canadian poultry producers.
Creamino® is a patent protected preparation of guanidinoacetic acid (GAA). GAA is the direct endogenous precursor of creatine in the organism of all vertebrates. The body produces GAA from the amino acids glycine and arginine, and creatine from GAA and methionine. However, this endogenous synthethis is not sufficient to meet daily needs. Until now, there is no Creatine in feed. Creatine is an essential biomolecule for proper function of energy transfer and supply. Thereby Creatine supports various functions in the body, such as healthy growth, immune system or reproduction. In contrast to other nutrients creatine directly reloads ATP for energy supply, making sure that sufficient energy is at any time and any place available in the body.
With Creamino®, we supply a unique source of creatine supporting many important body functions, delivering energy for healthy growth.
AlzChem is a globally active specialty chemicals company that is predominantly among the market leaders in its fields of activity. AlzChem benefits in particular from the three very different global megatrends of sustainability, population growth and healthy aging. AlzChem products offer attractive solutions in a wide range of applications.
The company sees interesting growth prospects for itself above all in the fields of human and animal nutrition, pharmaceuticals, agriculture, fine chemicals, metallurgy and renewable energies. The broad product range includes, for example, dietary supplements, plant growth regulators and precursors for corona tests.
The company employs around 1,630 people at four production sites in Germany and Sweden, and at two sales companies in the USA and China. In 2020, AlzChem generated consolidated sales of around EUR 379 million and EBITDA of around EUR 53.8 million.
Here you can find further information about our sales team